About Us

Imbrium Therapeutics is a clinical stage biopharmaceutical company dedicated to advancing medical science through the development of important new therapies to treat cancer, pain and disorders of the central nervous system.

Imbrium Therapeutics was founded in 2019 as an operating subsidiary of Purdue Pharma. With its distinct mission, therapy area focus, and leadership team, Imbrium is committed to applying its capabilities in science and medicine to rapidly advance the development of new, favorably differentiated therapeutic agents in the areas of cancer, CNS and non-opioid pain. Imbrium Therapeutics is committed to operating ethically and in full compliance with laws and regulations governing the pharmaceutical industry.

Contact Us